semaglutide with other medications like and tirzepatide (often used for type 2 diabetes and weight loss) are growing in popularity—but researchers are keeping a close eye on their safety. A new #NIHFunded study looked FDA Warns on Certain Forms

P., Morin, G

DOI: 10.1038/s41514-026-00383-9 The study was funded, in part, by the National Institutes of Health (grants P30 AI036214, UM1 AI068634, UM1 AI068636, UM1 AI106701) and the James B

Figure 2 Figure 3 3.3 Results of network meta-analysis The network plot is shown in Figure 4

Here are a few of the most common GLP-1 options and GLP-1 indications: Tirzepatide (GLP-1/GIP dual agonist) Mounjaro (type 2 diabetes) Zepbound (weight loss) Orforglipron Foundayo (weight loss) Semaglutide Ozempic & Rybelsus (type 2 diabetes) Wegovy & Wegovy Pill (weight loss) Dulaglutide Trulicity (type 2 diabetes) Liraglutide Victoza (type 2 diabetes) Saxenda (weight loss) The Benefits of GLP-1s GLP-1 medications dont just lower blood sugar and support weight loss

Furthermore, hepatic parameters improving with semaglutide treatment in the whole SELECT population, irrespective of MASH, offers a rationale for the integration of comprehensive management strategies that address the interconnected burden of hepatic and CV complications in people with overweight and obesity

If side effects are bothersome, the healthcare provider might keep the dose at the current level for more weeks or even lower it for a while